Guillain-Barre syndrome related to SARS-CoV-2 vaccinations

Finsterer, Josef; Scorza, Carla A.

doi:10.1016/j.clinsp.2022.100113

Cited by 5 publications

(5 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SC2V-related cerebrovascular diseases include VST, ischemic stroke, ICH, SAB, pituitary apoplexy, RCVS, cerebral vasculitis, and Susac syndrome ( Table 2 ) [ 4 , 6 …”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Neurological Adverse Reactions to SARS-CoV-2 Vaccines

Finsterer¹

2023

Clin Psychopharmacol Neurosci

Self Cite

View full text Add to dashboard Cite

SARS-CoV-2 vaccines are not free of side effects and most commonly affect the central or peripheral nervous system (CNS, PNS). This narrative review aims to summarise recent advances in the nature, frequency, management, and outcome of neurological side effects from SARS-CoV-2 vaccines. CNS disorders triggered by SARS-CoV-2 vaccines include headache, cerebro-vascular disorders (venous sinus thrombosis [VST], ischemic stroke, intracerebral hemorrhage, subarachnoid bleeding, reversible, cerebral vasoconstriction syndrome, vasculitis, pituitary apoplexy, Susac syndrome), inflammatory diseases (encephalitis, meningitis, demyelinating disorders, transverse myelitis), epilepsy, and a number of other rarely reported CNS conditions. PNS disorders related to SARS-CoV-2 vaccines include neuropathy of cranial nerves, mono-/polyradiculitis (Guillain-Barre syndrome [GBS]), Parsonage-Turner syndrome (plexitis), small fiber neuropathy, myasthenia, myositis/dermatomyositis, rhabdomyolysis, and a number of other conditions. The most common neurological side effects are facial palsy, intracerebral hemorrhage, VST, and GBS. The underlying pathophysiology is poorly understood, but several speculations have been generated to explain the development of CNS/PNS disease after SARS-CoV-2 vaccination. In conclusion, neurological side effects develop with any type of SARS-CoV-2 vaccine and are diverse, can be serious and even fatal, and should be taken seriously to initiate early treatment and improve outcome and avoid fatalities. KEY WORDS: Side effects; COVID-19 vaccination; Neurological; Brain; Nerves."venous sinus thrombosis", "multiple sclerosis", "acute disseminated encephalomyelitis", "seizure", "Guillain Barre syndrome", "Parsonage Turner syndrome", "myositis", and "myasthenia". In addition, reference lists were searched for additional articles that matched the search criteria. Neurological COVID Vaccination Complications 223Table 1. Most common marketed anti-SARS-CoV-2 vaccines Company Generic name Brand name Ⓡ Technology Number of dosages Biontech Pfizer BNT162b2 Comirnaty m-RNA Two/booster Moderna m-RNA1273 Spikevax m-RNA Two/booster Astra Zeneca ChAdOx1-S nCoV-19 Vaxzevira Viral vector Two/booster Curevac CVnCoV Zorecimeran m-RNA Two Novavax NVX-Cov2373 Novaxovid Protein subunit Two Johnson & Johnson Ad26.COV.2S Jcovden Viral vector One Sinovac CoronaVac CoronaVac Viral vector Two/booster Valneva VLA2001 COVID-19 vaccine Viral vector Two/booster Sinopharm COVID 2019 vaccine BIBP Viral vector Two/booster Gam-Covid-Vac Sputnik-V Gam-Covid-Vac Viral vector Two Bharat Biotech BBV152 Covaxin Viral vector Two/booster CanSino Biologics Ad5-nCoV Convidecia Viral vector Single Sinopharm BBIBP32-CorV Covilo Viral vector Two booster Sanofi Pasteur VidPrevtyn beta VidPrevtyn beta Protein subunit OneOriginal articles and reviews published between 1966 and December 2022 were included. Abstracts, proceedings, and editorials were excluded from data analysis. The review does not claim to be complete, since the number of words and references was...

show abstract

“…SC2V-related cerebrovascular diseases include VST, ischemic stroke, ICH, SAB, pituitary apoplexy, RCVS, cerebral vasculitis, and Susac syndrome ( Table 2 ) [ 4 , 6 …”

Section: Resultsmentioning

confidence: 99%

“…Clinical presentation and treatment of SC2V-related GBS is not at variance from GBS due to other causes. More than 300 cases of SC2V-related GBS have been reported to date [ 3 , 4 , 101 ]. Prevalence of SC2V-related GBS varies considerably between studies.…”

Section: Resultsmentioning

confidence: 99%

Neurological Adverse Reactions to SARS-CoV-2 Vaccines

Finsterer¹

2023

Clin Psychopharmacol Neurosci

Self Cite

View full text Add to dashboard Cite

show abstract

“…Most frequently its cause was immunization with AZV vaccines, followed by J&J and Pfizer vaccines. 41 J&J vaccines may be associated with very high incidence compared with mRNA-based vaccines. 42 In fact, GBS after mRNA vaccines may represent the background incidence of the syndrome.…”

Section: Guillain–barre Syndromementioning

confidence: 99%

A Narrative Review of Neurological Complications of SARS-CoV-2 Vaccination

Bithal,

Rajagopalan

2024

J Neuroanaesth Crit Care

View full text Add to dashboard Cite

Adverse reactions to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine depict a tropism for neural structures. This narrative review was aimed to discuss published data on the spectrum of neurological side effects of SARS-CoV-2 vaccines, which were accorded emergency use authorization. The majority of the neurological manifestations of SARS-CoV-2 vaccination are usually mild, brief, self-limiting, and easily manageable. Rarely, these side effects can be of serious nature and require hospitalization. High vigilance helps in early identification and treatment of these complications leading to good outcomes. The reported incidence of neurological complications in vaccinated population is a miniscule, and the overall benefits of the vaccine outweigh the risks of side effects. However, it is crucial to conduct larger collaborative multicenter studies to prove or reject the causal association between the SARS-CoV-2 vaccines and the postvaccination neurological side effects. Herein, we have tried to summarize the various neurological manifestations related to SARS-CoV-2 vaccines published in the literature from 2021 to mid-2023.

show abstract

“…As per the end of September 2021 at least 400 patients with SARS-CoV-2 vaccination related to GBS had been reported. 6 Among these patients, 9 patients had been vaccinated with BPV. 6 Therefore, GBS does not represent a rare adverse event, but is rather an established adverse reaction.…”

Section: Letter To the Editormentioning

confidence: 99%

“…6 Among these patients, 9 patients had been vaccinated with BPV. 6 Therefore, GBS does not represent a rare adverse event, but is rather an established adverse reaction.…”

Section: Letter To the Editormentioning

confidence: 99%